6-heptyne-2,5-diamine has been researched along with Benign Neoplasms in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cornbleet, MA; Haegele, KD; Joder-Ohlenbusch, AM; Kingsnorth, A; Smyth, JF; Tell, GP | 1 |
1 other study(ies) available for 6-heptyne-2,5-diamine and Benign Neoplasms
Article | Year |
---|---|
Phase I study of methylacetylenic putrescine, an inhibitor of polyamine biosynthesis.
Topics: Adult; Aged; Alkynes; Antineoplastic Agents; Diamines; Drug Evaluation; Female; Humans; Male; Middle Aged; Neoplasms; Polyamines; Putrescine; Reference Values; Spermidine; Spermine | 1989 |